Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 2Phase 3 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 4Seroma 2Postoperative Hemorrhage 2Leiomyoma 2Hemorrhage 2Blood Loss, Surgical 2Wrist Fractures 1Thromboembolism 1Stomach Neoplasms 1Sarcoma 1Polyposis, Gastric 1Ovarian Neoplasms 1Menorrhagia 1Meningioma 1Hematoma 1Hand Injuries 1Esophageal Neoplasms 1Edema 1Dupuytren Contracture 1Duodenal Neoplasms 1Disease 1Colorectal Surgery 1Colonic Neoplasms 1

Interventions

ulipristal acetate 9Leuprolide 4Uterine Artery Embolization 3ulipristal 2Tranexamic Acid 2Letrozole 2Bupivacaine 2ferrous sulfate 1elagolix 1dienogest 1cetrorelix 1Vitamin B 6 1Uterine Myomectomy 1Sodium Chloride 1Sirolimus 1Saline Solution 1Rocuronium 1Pregabalin 1Oxytocin 1Naproxen 1Misoprostol 1Mifepristone 1Lidocaine 1Ibuprofen 1Goserelin 1Gonadotropin-Releasing Hormone 1DMAC2L protein, human 1Celecoxib 1Anesthetics, Local 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Leiomyoma × Tranexamic Acid × Clear all
NCT03317795 2021-12-08

Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids

Mayo Clinic

Phase 4 Completed
18 enrolled 13 charts

Leiomyoma, Menorrhagia

NCT02825719 2020-04-09

Ulipristal Use in Chinese Population

Queen Mary Hospital, Hong Kong

Phase 4 Terminated
31 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡